DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 55 filers reported holding DERMA SCIENCES INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,839,000 | +11.3% | 353,718 | 0.0% | 1.62% | +40.4% |
| Q3 2016 | $1,652,000 | +18.5% | 353,718 | 0.0% | 1.15% | +4.2% |
| Q2 2016 | $1,394,000 | +27.1% | 353,718 | 0.0% | 1.10% | +16.8% |
| Q1 2016 | $1,097,000 | -32.1% | 353,718 | 0.0% | 0.95% | -34.4% |
| Q4 2015 | $1,616,000 | -3.9% | 353,718 | -0.9% | 1.44% | -13.6% |
| Q3 2015 | $1,681,000 | -37.2% | 356,918 | -4.5% | 1.67% | -26.3% |
| Q2 2015 | $2,677,000 | -15.5% | 373,918 | 0.0% | 2.26% | -6.9% |
| Q1 2015 | $3,167,000 | -11.6% | 373,918 | -2.8% | 2.43% | -14.2% |
| Q4 2014 | $3,582,000 | +11.8% | 384,794 | 0.0% | 2.83% | -12.3% |
| Q3 2014 | $3,205,000 | -27.9% | 384,794 | 0.0% | 3.23% | -23.3% |
| Q2 2014 | $4,448,000 | -8.8% | 384,794 | 0.0% | 4.22% | +0.5% |
| Q1 2014 | $4,879,000 | +690.8% | 384,794 | +575.0% | 4.19% | +560.3% |
| Q4 2013 | $617,000 | -12.6% | 57,009 | 0.0% | 0.64% | -17.6% |
| Q3 2013 | $706,000 | -7.2% | 57,009 | 0.0% | 0.77% | -30.8% |
| Q2 2013 | $761,000 | – | 57,009 | – | 1.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,148,292 | $13,275,000 | 5.90% |
| DAFNA Capital Management LLC | 384,794 | $4,448,000 | 4.22% |
| Consonance Capital Management LP | 1,451,692 | $16,782,000 | 2.50% |
| Broadfin Capital, LLC | 3,648,754 | $42,180,000 | 2.08% |
| Redmile Group, LLC | 600,677 | $6,944,000 | 0.84% |
| ORACLE INVESTMENT MANAGEMENT INC | 492,796 | $5,696,722,000 | 0.69% |
| Senvest Management, LLC | 593,665 | $6,863,000 | 0.60% |
| HealthCor Management, L.P. | 920,000 | $10,635,000 | 0.53% |
| Baker Brothers Advisors | 3,537,137 | $40,889,000 | 0.50% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 112,117 | $1,296,000 | 0.50% |